The article you requested is
Coadministration of Isoniazid and Antidepressant Drugs
J Clin Psychiatry 1996;57:550 [letter]
Copyright 1996 Physicians Postgraduate Press, Inc.
To view this item, select one of the options below.
Purchase this PDF for $30
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($129) or print + online ($166 individual).
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email
Letter to the Editor
Sir: Isonicotinylhydrazide, also known as isoniazid, is a
well-known agent for treatment of mycobacterial infections. It
is also used for prevention of tuberculosis, given 300 mg/day
for a period of at least 6 months. In vivo studies, using
benzylamine as substrate, have demonstrated that isoniazid in
therapeutic doses inhibits plasma monoamine oxidase (MAO)
with no significant effect on platelet MAO.